Gapping up
In reaction to earnings/guidance/SSS: DRWI +6.7%, BURBY +5.4%, ZUMZ +5.1%, .
M&A news: IGT +5.9% (renewed GTech (GTKYY) bid speculation).
Select metals/mining stocks trading higher: KGC +3%, AG +2.9%, IAG +2.2%, SLW +2%, GG +1.9%, AU +1.8%, SLV +1.7%, ABX +1.7%, GDX +1.7%, GFI +1.2%, GLD +1.1%, GOLD +1%
Other news: UAL +4.8% (reports June 2014 consolidated traffic (RPM) was flat y/y and consolidated capacity (ASM) increased 0.8% vs June 2013), NG +2.6% ( reports major progress in advancing Donlin Gold up the Value Chain), SIR +1.2% (CommonWealth REIT sells its 22 mln shares of Select Income REIT for $31.51 per share), APP +1.2% (entered into a Nomination, Standstill and Support Agreement with Standard General and Dov Charney), SSE +0.9% (Carl Icahn disclosed 9.98% stake in 13D filing), REGN +0.9% (co and Sanofi (SNY) announced positive results from Phase 2b study of dupilumab in patients with moderate-to-severe atopic dermatitis), PAYX +0.7% (increases quarterly dividend), .
Analyst comments: MRC +2.1% (upgraded to Neutral from Underperform at BofA/Merrill
)
In reaction to earnings/guidance/SSS: DRWI +6.7%, BURBY +5.4%, ZUMZ +5.1%, .
M&A news: IGT +5.9% (renewed GTech (GTKYY) bid speculation).
Select metals/mining stocks trading higher: KGC +3%, AG +2.9%, IAG +2.2%, SLW +2%, GG +1.9%, AU +1.8%, SLV +1.7%, ABX +1.7%, GDX +1.7%, GFI +1.2%, GLD +1.1%, GOLD +1%
Other news: UAL +4.8% (reports June 2014 consolidated traffic (RPM) was flat y/y and consolidated capacity (ASM) increased 0.8% vs June 2013), NG +2.6% ( reports major progress in advancing Donlin Gold up the Value Chain), SIR +1.2% (CommonWealth REIT sells its 22 mln shares of Select Income REIT for $31.51 per share), APP +1.2% (entered into a Nomination, Standstill and Support Agreement with Standard General and Dov Charney), SSE +0.9% (Carl Icahn disclosed 9.98% stake in 13D filing), REGN +0.9% (co and Sanofi (SNY) announced positive results from Phase 2b study of dupilumab in patients with moderate-to-severe atopic dermatitis), PAYX +0.7% (increases quarterly dividend), .
Analyst comments: MRC +2.1% (upgraded to Neutral from Underperform at BofA/Merrill
)